Key Slides: AASLD Guidance on Evaluating Liver Fibrosis and Inflammation in Hepatitis B Infection

Review key data and AASLD guideline recommendations on methods to evaluate liver fibrosis and inflammation to guide management decisions for patients with HBV infection.
Anna Christina L. dela Cruz, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.27 MB
Released: April 20, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from:
Gilead Sciences, Inc.

Related Content

Review key slides on the interplay of COVID-19 and viral hepatitis and review expert strategies for managing chronic liver disease in the COVID-19 era

Released: January 10, 2022

Clinical Care Options (CCO) commentary by Dr. Dominique Braun on the results of the Swiss HCVree Trial: HCV testing, treatment, and counseling in MSM with HIV and HCV

Dominique Laurent Braun, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 10, 2022 Expired: January 9, 2023

Limitations of the APASL guidelines and potential role of using HBcrAg for treatment candidacy and HCC screening, from Clinical Care Options (CCO)

Yasuhito Tanaka, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 3, 2022 Expired: January 2, 2023

Dr. Jean-Michel Pawlotsky: guidance from EASL on the treatment of patients with HBV and cirrhosis, from Clinical Care Options (CCO)

Jean-Michel Pawlotsky, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 20, 2021 Expired: December 19, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings